Unicycive Share Price

Unicycive Share Price

NASDAQ: UNCY | Micro Cap | Healthcare
$3.35
-$0.19 (-5.23%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Unicycive Stock Performance

Open
$3.48
Prev. Close
$3.54
Circuit Range
N/A
Day Range
$3.35 - $3.62
Year Range
$3.33 - $8.74
Volume
88,735
Average Traded
$3.46

Unicycive Share Price Today

As of 21 November 2026, Unicycive Therapeutics, Inc.'s share price is $3.35. The stock opened at $3.48, compared to its previous close of $3.54. During today's trading session, Unicycive Therapeutics, Inc.'s share price traded between $3.35 and $3.62, with an average price of $3.48. Over the past 52 weeks, the stock has recorded a high of $8.74 and a low of $3.33. In terms of performance, Unicycive Therapeutics, Inc.'s share price has declined by 54.48% over the last six months and is down 48.14% on a year-on-year basis.

Unicycive Share Price Chart

Line chart of the Unicycive price trend over the selected period. The price fell overall, ranging from 3.35 to 3.62, ending at 3.35.
$3.35$3.62
L
Show Current Price
H

Unicycive Stock Fundamentals & Key Indicators

Market Cap
$53.22M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.24
Revenue (TTM)
$0.00
Return On Equity (TTM)
-68.81%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
52.28%

Unicycive Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.67-$12.82-$1.72-$7.00
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A12.61%86.58%-306.98%

Unicycive Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.95$0.68$0.00$0.00
Net Profit-$18.06-$31.41-$37.82-$26.56
Net Profit Margin-1901.05%-4619.12%N/AN/A
Income ChangeN/A-73.92%-20.41%29.77%

Unicycive Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.170.720.790.17
Current Assets48.9630.9513.42.64
Total Assets49.1431.6714.192.82
Non Current Liabilities0.00.120.470.0
Current Liabilities18.9424.1217.533.28
Total Liabilities18.9424.2418.03.28
Shareholders' Equity30.27.43-3.81-0.47

Unicycive Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-31.32-28.58-18.28-15.65
Investing-12.1-0.07-0.010.0
Financing46.4745.0927.54-0.47

Corporate Actions

Split
Ex-date: 20 Jun 2025

About Unicycive

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Unicycive Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.60
$3.35
-10.55%
Oct 2026
$4.71
$3.75
-20.32%
Sep 2026
$5.17
$4.70
-14.39%
Aug 2026
$5.00
$5.49
+9.47%
Jul 2026
$4.58
$5.01
+6.03%
Jun 2026
$7.50
$4.73
-35.73%
May 2026
$7.72
$7.36
-3.92%
Apr 2026
$6.78
$7.66
+16.50%
Mar 2026
$6.70
$6.58
-5.26%
Feb 2026
$6.00
$6.94
+16.54%
Jan 2026
$5.79
$5.96
+3.21%
Dec 2025
$6.42
$5.77
-10.68%

Unicycive Share Price FAQs